Cited 0 times in 
Cited 0 times in 
SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 조병철 | - |
| dc.date.accessioned | 2023-06-02T01:12:42Z | - |
| dc.date.available | 2023-06-02T01:12:42Z | - |
| dc.date.issued | 2022-02 | - |
| dc.identifier.issn | 0732-183X | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194732 | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | American Society of Clinical Oncology | - |
| dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Karyn A. Goodman | - |
| dc.contributor.googleauthor | Rui-hua Xu | - |
| dc.contributor.googleauthor | Ian Chau | - |
| dc.contributor.googleauthor | Ming Huang Chen | - |
| dc.contributor.googleauthor | Byoung Chul Cho | - |
| dc.contributor.googleauthor | Manish A. Shah | - |
| dc.contributor.googleauthor | Kei Muro | - |
| dc.contributor.googleauthor | Yifan Wang | - |
| dc.contributor.googleauthor | Mari Ichimaru | - |
| dc.contributor.googleauthor | Qingyuan Liu | - |
| dc.contributor.googleauthor | Luhua Wang | - |
| dc.identifier.doi | 10.1200/JCO.2022.40.4_suppl.TPS374 | - |
| dc.contributor.localId | A03822 | - |
| dc.relation.journalcode | J01331 | - |
| dc.identifier.eissn | 1527-7755 | - |
| dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.TPS374 | - |
| dc.contributor.alternativeName | Cho, Byoung Chul | - |
| dc.contributor.affiliatedAuthor | 조병철 | - |
| dc.citation.volume | 40 | - |
| dc.citation.number | 4 suppl | - |
| dc.citation.startPage | TPS374 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : TPS374, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.